Israel Studying Efficacy of Fourth Vaccine Dose Amid Omicron Surge

As Omicron continues to spread across the globe, a hospital in Israel on Monday began a study to test the effectiveness of a fourth COVID-19 vaccine dose. Officials at Sheba Medical Center near Tel Aviv said the study is the first of its kind and involves giving an additional shot to 150 medical personnel who […]

  • by:
  • 03/02/2023

As Omicron continues to spread across the globe, a hospital in Israel on Monday began a study to test the effectiveness of a fourth COVID-19 vaccine dose. Officials at Sheba Medical Center near Tel Aviv said the study is the first of its kind and involves giving an additional shot to 150 medical personnel who […]

As Omicron continues to spread across the globe, a hospital in Israel on Monday began a study to test the effectiveness of a fourth COVID-19 vaccine dose.

Officials at Sheba Medical Center near Tel Aviv said the study is the first of its kind and involves giving an additional shot to 150 medical personnel who had already received a booster at least four months ago, the New York Times reports

With studies showing that COVID-19 vaccines protect people from serious illness, a panel of medical experts advising the Israeli government recommended last week that health officials offer a fourth shot for those over the age of 60, with weaker immune systems and medical workers,

The proposal is awaiting formal approval from the Ministry of Health, but concerns have been raised about whether the recommendation is premature given the lack of data. 

Most of the advisory panel argued the benefits of a fourth dose outweigh the risks, but some argued not enough is known about the effects of a fourth dose. Indeed, some scientists have raised concerns that too many shots could cause some kind of immune system fatigue and compromise the body’s ability to fight the virus. 

A senior Israeli Health Ministry official said last week that they would gather more data from other countries, especially about the risk of severe illness among older people, before deciding on whether to offer a fourth dose. 

Image: by is licensed under
ADVERTISEMENT

Opinion

View All

OLIVER GHORBANIFAR: The one state that could win it all for Trump

Trump might want to hedge his bets by focusing more on Wisconsin, a state that is often underapprecia...

AUSTIN PETERSEN: The libertarian case for Trump

The idea that Ron Paul could make a triumphant return to DC, enabled by a President Trump and Elon Mu...

Keir Starmer to deploy drones as part of £75 million funding package to help UK officials detain migrant smugglers

"We have got to combine resources, share intelligence and tactics, and tackle the problem upstream, w...

Israel's Foreign Ministry cancels agreement with UNRWA

Last week, a law was passed by the Knesset severing all ties between Israel and UNRWA after employees...